Cited by 51SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesZoonotic diseases and public health

Understanding bat SARS-like coronaviruses for the preparation of future coronavirus outbreaks—implications for coronavirus vaccine development

Open access
Ng, Oi-Wing, Tan, Yee-Joo·2017·Human Vaccines & Immunotherapeutics

Abstract

The severe acute respiratory syndrome coronavirus (SARS-CoV) first emerged in 2003, causing the SARS epidemic which resulted in a 10% fatality rate. The advancements in metagenomic techniques have allowed the identification of SARS-like coronaviruses (SL-CoVs) sequences that share high homology to the human SARS-CoV epidemic strains from wildlife bats, presenting concrete evidence that bats are the origin and natural reservoir of SARS-CoV. The application of reverse genetics further enabled that characterization of these bat CoVs and the prediction of their potential to cause disease in humans. The knowledge gained from such studies is valuable in the surveillance and preparation of a possible future outbreak caused by a spill-over of these bat SL-CoVs.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/21645515.2016.1228500

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Bioengineering of SARS-CoV-like viruses for studying and testing drugs and vaccines advanced substantially after the SARS outbreak in the 2000s.

    “The bioengineering of SARS-CoV-like viruses for the study and testing of potential drugs and vaccines advanced substantially after the outbreak of severe acute respiratory syndrome in the 2000s.52, 64”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ng, O.-W., & Tan, Y.-J.
Affiliations
  • National University of Singapore (SG)
  • Agency for Science, Technology and Research (SG)
Corresponding author
Tan, Yee-Joo
Venue
Human Vaccines & Immunotherapeutics
Published
2016-11-10
Volume
13
Issue
1
Pages
186-189
ISSN
  • 2164-5515 (ISSN-L)
  • 2164-554X
OpenAlex
W2522824033
Cited by
51
References
29
Citations by year
2024: 2 · 2023: 2 · 2022: 4 · 2021: 12 · 2020: 17 · 2019: 11 · 2018: 2 · 2017: 1
Type
journal article
Language
en
Open access
Locations
  • Human Vaccines & Immunotherapeutics (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • National University of Singapore (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • British Sedimentological Research Group
  • National University Health System
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Zoonotic diseases and public health
Keywords
SARS-like coronaviruses, bats, SARS-CoV, zoonotic spillover, natural reservoirs, metagenomics, reverse genetics, epidemic preparedness, wildlife monitoring
MeSH terms
Animals, Chiroptera, Disease Outbreaks, Humans, Viral Vaccines, Severe Acute Respiratory Syndrome, Severe acute respiratory syndrome-related coronavirus, High-Throughput Nucleotide Sequencing, Reverse Genetics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review